0,724  0,015  Antineoplastic (lung cancer)
0,669  0,008  Antineoplastic (melanoma)
0,636  0,006  Antiprotozoal (Leishmania)
0,637  0,020  Antileukemic
0,618  0,045  Apoptosis agonist
0,573  0,015  5 Hydroxytryptamine release inhibitor
0,583  0,025  Antineoplastic (colorectal cancer)
0,579  0,024  Antineoplastic (colon cancer)
0,547  0,005  Skin whitener
0,543  0,005  Lipid peroxidase inhibitor
0,538  0,005  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,547  0,044  Antineoplastic (breast cancer)
0,513  0,019  Antiischemic
0,518  0,024  Antineoplastic (ovarian cancer)
0,501  0,020  AR expression inhibitor
0,503  0,028  Histamine release inhibitor
0,475  0,005  Ca2+/calmodulin-dependent kinase I alpha inhibitor
0,496  0,027  GABA C receptor rho-3 antagonist
0,491  0,023  Antineoplastic (cervical cancer)
0,471  0,008  Diabetic retinopathy treatment
0,481  0,022  Antineoplastic (glioma)
0,454  0,013  Antineoplastic (lymphocytic leukemia)
0,475  0,046  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,452  0,026  Antioxidant
0,451  0,027  Antineoplastic (brain cancer)
0,464  0,043  Calcium channel L-type activator
0,464  0,046  Antiprotozoal
0,422  0,006  Interleukin 6 antagonist
0,443  0,029  NOS3 expression inhibitor
0,451  0,037  Ulceration
0,425  0,019  Vasodilator
0,430  0,027  Antineoplastic (non-small cell lung cancer)
0,408  0,014  Antineoplastic (bladder cancer)
0,411  0,017  RNA-directed DNA polymerase inhibitor
0,415  0,023  Antiparasitic
0,415  0,024  Dyrk kinase inhibitor
0,415  0,026  Free radical scavenger
0,390  0,012  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,396  0,029  DNA damaging
0,392  0,026  Antineoplastic (renal cancer)
0,381  0,023  Peroxidase inhibitor
0,374  0,019  Antihelmintic
0,362  0,010  NOS3 expression enhancer
0,457  0,107  Antiinflammatory
0,383  0,035  CYP1A2 inhibitor
0,369  0,023  Ca2+/calmodulin-dependent protein kinase inhibitor
0,378  0,037  Cytostatic
0,365  0,029  Antimitotic
0,367  0,032  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,376  0,044  Cardioprotectant
0,386  0,062  Stroke treatment
0,327  0,010  Insulin secretagoues
0,344  0,027  Ca2+/calmodulin-dependent kinase II gamma inhibitor
0,352  0,036  Antineoplastic (glioblastoma multiforme)
0,383  0,067  Transcription factor NF kappa B inhibitor
0,314  0,009  CDC-like kinase 1 inhibitor
0,324  0,023  Antihypotensive
0,363  0,066  Antiprotozoal (Plasmodium)
0,346  0,052  Lipoxygenase inhibitor
0,350  0,056  Apoptosis antagonist
0,304  0,013  Antidiarrheal
0,314  0,027  Tyrosine 3 hydroxylase inhibitor
0,289  0,004  Prostaglandin-E synthase inhibitor
0,300  0,018  Neurotrophic factor enhancer
0,313  0,033  Ca2+/calmodulin-dependent kinase II beta inhibitor
0,299  0,028  Antianginal
0,339  0,069  Prostate cancer treatment
0,299  0,030  MAP-kinase-activated kinase 5 inhibitor
0,382  0,122  Caspase 9 stimulant
0,324  0,066  Antimycobacterial
0,279  0,022  Tubulin antagonist
0,283  0,034  Myocardial ischemia treatment
0,287  0,038  Platelet adhesion inhibitor
0,294  0,045  Antineoplastic (sarcoma)
0,310  0,066  Spasmolytic
0,247  0,006  Photosensitizer
0,242  0,005  Potassium channel activator
0,294  0,059  Antiprotozoal (Trypanosoma)
0,253  0,018  Interleukin 1 antagonist
0,293  0,058  NOS2 expression inhibitor
0,296  0,068  Hypoxia-inducible factor 1 alpha inhibitor
0,298  0,070  5 Hydroxytryptamine release stimulant
0,283  0,059  Antidiabetic symptomatic
0,220  0,008  Hearing loss treatment
0,220  0,009  MAP3K9 inhibitor
0,289  0,078  CTGF expression inhibitor
0,220  0,011  Potassium channel (Ca-activated) activator
0,258  0,051  Antineoplastic enhancer
0,255  0,050  Nitric oxide antagonist
0,269  0,064  Proliferative diseases treatment
0,262  0,057  Interleukin antagonist
0,266  0,063  Acute neurologic disorders treatment
0,235  0,033  Contraceptive
0,214  0,013  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,296  0,096  Calcium channel activator
0,220  0,023  Death-associated protein kinase 2 inhibitor
0,252  0,054  Clk dual-specificity kinase inhibitor
0,225  0,032  5 Hydroxytryptamine 3E antagonist
0,293  0,101  Vasodilator, peripheral
0,218  0,028  Cyclooxygenase 1 inhibitor
0,221  0,033  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,237  0,055  Chemopreventive
0,190  0,009  Electron transport complex I inhibitor
0,214  0,038  VEGF expression inhibitor
0,223  0,049  Male reproductive disfunction treatment
0,182  0,010  CDC-like kinase 3 inhibitor
0,184  0,016  Dementia treatment
0,198  0,030  GABA C receptor rho-2 antagonist
0,206  0,039  Cyclooxygenase inhibitor
0,247  0,080  Aryl hydrocarbon receptor agonist
0,197  0,032  Cyclooxygenase 2 inhibitor
0,258  0,093  CYP1A2 substrate
0,183  0,018  Contraceptive female
0,187  0,022  Antischistosomal
0,180  0,015  Vascular dementia treatment
0,252  0,089  Antituberculosic
0,171  0,010  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,256  0,099  Streptokinase A inhibitor
0,170  0,015  Actinic keratosis treatment
0,210  0,056  Histone acetyltransferase inhibitor
0,190  0,036  Antifungal enhancer
0,172  0,019  TRPA1 agonist
0,269  0,116  Vasodilator, coronary
0,160  0,012  MAP-kinase-activated kinase inhibitor
0,219  0,071  Cytotoxic
0,211  0,064  Pneumotoxic
0,211  0,066  Wound healing agent
0,218  0,072  Pyruvate kinase inhibitor
0,188  0,047  Melanin inhibitor
0,151  0,010  MAP-kinase-activated kinase 2 inhibitor
0,173  0,033  Farnesoid X receptor antagonist
0,245  0,105  GST M1-1 substrate
0,142  0,003  Retinoic acid alpha receptor agonist
0,174  0,037  Protein-tyrosine phosphatase 1B inhibitor
0,166  0,030  Pregnane X receptor agonist
0,201  0,066  CDC-like kinase 2 inhibitor
0,232  0,098  Amyotrophic lateral sclerosis treatment
0,282  0,149  Antibacterial
0,149  0,016  Contraceptive male
0,157  0,026  Antineoplastic alkaloid
0,170  0,040  Monophenol monooxygenase inhibitor
0,184  0,054  Protein-tyrosine phosphatase inhibitor
0,144  0,015  Cyclin B3 inhibitor
0,158  0,029  Bronchodilator
0,150  0,021  Protein kinase C delta inhibitor
0,164  0,036  Topoisomerase I inhibitor
0,222  0,095  Hypoglycemic
0,159  0,036  Cyclin-dependent kinase 5 inhibitor
0,136  0,014  Bromodomain-containing protein 2 inhibitor
0,155  0,035  Heat shock protein 70 antagonist
0,225  0,105  Ca2+/calmodulin-dependent kinase IV inhibitor
0,247  0,131  FMO1 substrate
0,141  0,026  Nitric-oxide synthase inhibitor
0,187  0,074  CDC-like kinase 4 inhibitor
0,223  0,110  Antineoplastic (pancreatic cancer)
0,127  0,015  Potassium channel large-conductance Ca-activated activator
0,160  0,048  Psychosexual dysfunction treatment
0,210  0,100  Antipyretic
0,146  0,036  Butyrylcholinesterase inhibitor
0,150  0,040  Death-associated protein kinase 1 inhibitor
0,174  0,066  Urinary incontinence treatment
0,265  0,158  CYP2C19 inhibitor
0,191  0,085  Psychostimulant
0,137  0,031  Urease inhibitor
0,145  0,040  5-Lipoxygenase inhibitor
0,146  0,042  Cyclin-dependent kinase 1 inhibitor
0,126  0,022  Inducible nitric-oxide synthase inhibitor
0,147  0,043  MAP kinase 12 inhibitor
0,236  0,133  Antihypertensive
0,128  0,026  Antithrombocytopenic
0,141  0,040  MAP kinase 13 inhibitor
0,118  0,019  Glycine receptor antagonist
0,156  0,059  SULT1A3 substrate
0,215  0,121  UGT2B4 substrate
0,202  0,108  Vascular (periferal) disease treatment
0,209  0,117  UGT1A9 substrate
0,123  0,033  Alcohol dehydrogenase inhibitor
0,117  0,027  Antifungal (Candida)
0,190  0,103  Antiviral (HIV)
0,177  0,090  Death-associated protein kinase 3 inhibitor
0,122  0,036  DNA directed RNA polymerase inhibitor
0,091  0,005  Potassium channel (Inward rectifier) activator
0,155  0,070  Heat shock protein 90 antagonist
0,115  0,030  Phosphodiesterase 6D inhibitor
0,208  0,124  CYP2C19 substrate
0,088  0,005  Potassium channel (ATP-sensitive) activator
0,123  0,042  Carbonic anhydrase III inhibitor
0,091  0,010  Transcription factor RelA inhibitor
0,150  0,070  Movement disorders treatment
0,211  0,132  5 Hydroxytryptamine uptake stimulant
0,099  0,021  Phosphodiesterase VI inhibitor
0,131  0,054  Interleukin 1b antagonist
0,094  0,016  Aryl hydrocarbon receptor antagonist
0,165  0,089  Carcinogenic
0,137  0,061  Liver cirrhosis treatment
0,142  0,067  Ca2+-transporting ATPase inhibitor
0,215  0,142  FMO3 substrate
0,199  0,128  Antiosteoporotic
0,121  0,051  GABA C receptor antagonist
0,189  0,119  Antineoplastic (liver cancer)
0,107  0,039  Pim-3 kinase inhibitor
0,181  0,113  UGT1A6 substrate
0,188  0,120  Tumour necrosis factor alpha release inhibitor
0,104  0,036  Carbonic anhydrase XIII inhibitor
0,200  0,134  Chemoprotective
0,120  0,056  SULT1A1 substrate
0,146  0,083  CF transmembrane conductance regulator agonist
0,137  0,074  Antineoplastic (squamous cell carcinoma)
0,094  0,031  Estrogen receptor alpha antagonist
0,112  0,050  Gastric antisecretory
0,074  0,012  Progesterone antagonist
0,096  0,038  Phosphodiesterase 4D inhibitor
0,108  0,052  GABA C receptor rho-1 antagonist
0,137  0,081  Antifungal (Cryptococcus)
0,158  0,103  Antiviral (Hepatitis)
0,193  0,139  5 Hydroxytryptamine 1E antagonist
0,116  0,062  Estrogen antagonist
0,145  0,092  Heat shock protein 90 alpha antagonist
0,124  0,071  Papain-like protease (SARS coronavirus) inhibitor
0,099  0,046  Ornithine decarboxylase inhibitor
0,203  0,151  Hepatic disorders treatment
0,124  0,072  MAO inhibitor
0,068  0,016  Pregnane X receptor antagonist
0,054  0,003  Toll-Like receptor 4 agonist
0,060  0,010  Acid-sensing ion channel blocker
0,112  0,063  DNA intercalator
0,110  0,062  Protein kinase C gamma inhibitor
0,076  0,028  TRPA1 antagonist
0,208  0,160  Angiogenesis inhibitor
0,089  0,042  Na+ K+ transporting ATPase inhibitor
0,091  0,043  NAD(P)H dehydrogenase (quinone) inhibitor
0,052  0,005  Retinoic acid receptor agonist
0,099  0,052  Bile acid receptor antagonist
0,101  0,054  Prolactin inhibitor
0,077  0,030  5 Hydroxytryptamine 2A agonist
0,148  0,103  Tumour necrosis factor antagonist
0,157  0,111  Antirickettsial
0,115  0,070  Antiprotozoal (Babesia)
0,079  0,035  Peroxisome proliferator-activated receptor gamma antagonist
0,122  0,077  Retinoprotector
0,083  0,038  MAP kinase kinase 7 inhibitor
0,084  0,040  HIV-1 reverse transcriptase inhibitor
0,220  0,177  CYP2C9 substrate
0,182  0,139  Radioprotector
0,071  0,029  Androgen agonist
0,106  0,065  Ferrochelatase inhibitor
0,096  0,056  Alpha 2d adrenoreceptor antagonist
0,057  0,017  Cytokine production stimulant
0,104  0,064  NAT2 substrate
0,087  0,048  Topoisomerase II alpha inhibitor
0,065  0,027  Cyclin B2 inhibitor
0,133  0,095  Adenylate cyclase stimulant
0,158  0,120  Anticonvulsant
0,101  0,063  Estrogen receptor beta antagonist
0,087  0,050  Carbonic anhydrase VI inhibitor
0,148  0,111  Hepatoprotectant
0,057  0,022  Mineralocorticoid receptor antagonist
0,178  0,144  Superoxide dismutase inhibitor
0,071  0,038  Potassium channel (ATP-sensitive) blocker
0,108  0,077  Microtubule formation inhibitor
0,200  0,169  Caspase 3 stimulant
0,049  0,018  Hypogonadism treatment
0,117  0,087  NADPH oxidase inhibitor
0,051  0,022  Poly(ADP-ribose) polymerase inhibitor
0,121  0,092  Protein kinase stimulant
0,065  0,036  5 Hydroxytryptamine 5A antagonist
0,053  0,026  Aldosterone antagonist
0,107  0,080  Carcinogenic, group 3
0,064  0,039  Cyclin B1 inhibitor
0,087  0,064  Antidote, mercury
0,068  0,046  Andropause treatment
0,083  0,061  Androgen antagonist
0,164  0,143  VCAM1 expression inhibitor
0,082  0,062  D-Ala-D-Ala ligase inhibitor
0,056  0,036  Cyclin B inhibitor
0,036  0,016  Estrogen-related receptor beta antagonist
0,111  0,092  Glycogen synthase kinase-3 alpha inhibitor
0,112  0,094  Antiviral (Papilloma)
0,112  0,093  Gastritis treatment
0,027  0,009  Imidazoline I1 receptor antagonist
0,058  0,040  5 Hydroxytryptamine 5 antagonist
0,026  0,009  Retinoic acid alpha receptor antagonist
0,040  0,023  Poly(ADP-ribose) polymerase 1 inhibitor
0,052  0,036  5 Hydroxytryptamine 2 agonist
0,023  0,007  Follicle-stimulating hormone antagonist
0,061  0,046  HIV-1 integrase (3'-Processing) inhibitor
0,201  0,185  GST A substrate
0,101  0,085  Topoisomerase II inhibitor
0,089  0,075  Carcinogenic, group 2B
0,128  0,115  Arachidonic acid antagonist
0,134  0,120  Sedative
0,058  0,045  Cyclin D1 inhibitor
0,155  0,141  Antihypercholesterolemic
0,108  0,096  Coagulant
0,036  0,024  Retinoid X receptor agonist
0,118  0,106  Mutagenic
0,046  0,034  Potassium channel Kv1.3 blocker
0,100  0,089  Beta amyloid protein antagonist
0,099  0,089  Cholesterol synthesis inhibitor
0,055  0,045  HIV-1 integrase (Strand Transfer) inhibitor
0,097  0,087  Antifungal (Aspergillus)
0,031  0,022  Liver X receptor antagonist
0,088  0,079  Electrolyte absorption antagonist
0,063  0,054  Check point kinase 1 inhibitor
0,113  0,105  UGT2B15 substrate
0,020  0,012  Retinoic acid receptor antagonist
0,064  0,055  Glutamate (mGluR6) antagonist
0,157  0,151  Cardiovascular analeptic
0,088  0,082  Anabolic
0,095  0,089  GST T1-1 substrate
0,013  0,008  Retinoic acid beta receptor antagonist
0,139  0,134  UGT1A1 substrate
0,095  0,091  Antihypermotility
0,112  0,109  Neurotrophic factor
0,103  0,101  Ca2+/calmodulin-dependent kinase II delta inhibitor
0,144  0,142  Antiulcerative
0,100  0,098  Interleukin 8 antagonist
0,011  0,009  Retinoic acid receptor gamma antagonist
0,194  0,193  CYP3A4 substrate
0,020  0,019  Follicle-stimulating hormone agonist
0,039  0,038  GABA B receptor antagonist
0,081  0,080  MAO A inhibitor

